```html

Quinolone‑Induced Tendonitis

What is Quinolone‑Induced Tendonitis?

Quinolone‑induced tendonitis is an inflammation of a tendon that occurs as an adverse reaction to fluoroquinolone antibiotics (e.g., ciprofloxacin, levofloxacin, moxifloxacin). The tendons most often affected are the Achilles tendon and the tendons of the shoulders, but any tendon can become inflamed. The condition typically develops within a few days to several weeks after starting the medication, and it may resolve after stopping the drug, although some patients experience persistent pain or even tendon rupture.

Fluoroquinolones are broad‑spectrum antibiotics used for respiratory, urinary‑tract, skin, and gastrointestinal infections. While they are generally safe, they have a well‑documented association with connective‑tissue toxicity, which includes tendonitis, tendon rupture, and, less commonly, cartilage damage. The exact mechanism is not fully understood, but it appears to involve oxidative stress, disruption of collagen synthesis, and direct toxicity to tendon fibroblasts.<sup>[1]</sup>

Common Causes

Quinolone‑induced tendonitis is specifically linked to the use of fluoro‑quinolone antibiotics, but several additional factors increase the risk.

• Use of fluoroquinolone antibiotics (ciprofloxacin, levofloxacin, moxifloxacin, ofloxacin, etc.)
• Age ≥ 60 years – tendon tissue becomes less resilient with age.
• Concurrent corticosteroid therapy – steroids weaken tendons.
• Renal insufficiency or dialysis – altered drug clearance leads to higher tissue exposure.
• Physical activity that stresses the tendons (running, jumping, heavy lifting) while on therapy.
• History of previous tendon disorders or prior fluoroquinolone exposure.
• Diabetes mellitus – microvascular changes affect tendon health.
• Obesity – increased mechanical load on weight‑bearing tendons.
• Genetic predisposition (e.g., collagen‑type gene variants) – still under investigation.

Associated Symptoms

Patients with quinolone‑induced tendonitis often notice a constellation of signs that mirror other forms of tendon inflammation.

• Gradual or sudden onset of pain localized to the tendon (commonly Achilles, rotator cuff, or hand extensors).
• Swelling, warmth, or a feeling of “tightness” around the affected area.
• Stiffness, especially after periods of inactivity (e.g., getting out of bed).
• Reduced range of motion or difficulty bearing weight on the affected limb.
• Audible crepitus or a “popping” sensation when moving the joint.
• In severe cases, a sudden “snap” indicating tendon rupture, followed by immediate loss of function.

When to See a Doctor

Prompt medical evaluation is essential to prevent permanent tendon damage. Contact a health‑care provider if you experience any of the following while taking a fluoroquinolone:

• New or worsening tendon pain that does not improve with rest.
• Swelling, redness, or warmth over a tendon.
• Difficulty walking or climbing stairs (especially if the Achilles tendon is involved).
• Sudden loss of strength in the affected limb.
• A “popping” or “snapping” sensation during movement.
• Persistent pain that continues for more than 48–72 hours after stopping the antibiotic.

If you have any of the red‑flag symptoms listed in the “Emergency Warning Signs” section, seek emergency care immediately.

Diagnosis

Diagnosing quinolone‑induced tendonitis involves a combination of clinical assessment, patient history, and, when necessary, imaging studies.

1. Clinical History

• Documentation of fluoroquinolone exposure: drug name, dose, duration, and start date.
• Identification of risk factors (age, steroids, renal disease, recent intense exercise).
• Symptom timeline relative to medication use.

2. Physical Examination

• Palpation of the tendon to assess tenderness, swelling, and temperature.
• Range‑of‑motion testing to detect pain‑limited movement.
• Strength testing to uncover weakness that may precede rupture.

3. Imaging

• Ultrasound: First‑line, bedside tool to evaluate tendon thickness, edema, and partial tears.
• MRI: Provides detailed visualization of tendon integrity and surrounding structures; useful if ultrasound is inconclusive.
• X‑ray: Not diagnostic for tendonitis but may be ordered to rule out bony pathology.

4. Laboratory Tests (optional)

• Inflammatory markers (ESR, CRP) – usually normal in isolated tendonitis but can help exclude systemic disease.
• Renal function tests – important for adjusting fluoroquinolone dosing and assessing risk.

Treatment Options

Treatment focuses on removing the offending drug, alleviating inflammation, and protecting the tendon from further injury.

1. Immediate Measures

• Discontinue the fluoroquinolone as soon as tendonitis is suspected. Substitute with an alternative antibiotic (e.g., amoxicillin–clavulanate, doxycycline) after consulting the prescribing clinician.
• Rest the affected limb; avoid weight‑bearing or activities that stress the tendon.
• Apply ice packs for 15–20 minutes every 2–3 hours during the first 48 hours to reduce swelling.

2. Pharmacologic Therapy

• Non‑steroidal anti‑inflammatory drugs (NSAIDs): Ibuprofen 400–600 mg every 6–8 hours or naproxen 500 mg twice daily, unless contraindicated.
• Acetaminophen: For pain control if NSAIDs are unsuitable.
• Short‑course oral corticosteroids (e.g., prednisone 10–20 mg daily for 5–7 days) may be considered in severe inflammation, but the overall risk of tendon rupture may increase; use only under specialist guidance.

3. Physical Therapy & Rehabilitation

• Gentle **stretching** of the involved tendon after the acute pain subsides (usually after 48–72 hours).
• Progressive **strengthening** exercises (eccentric loading for Achilles tendon) performed under the supervision of a physical therapist.
• Modalities such as **ultrasound therapy**, **low‑level laser**, or **contrast baths** can aid tissue healing.

4. Surgical Intervention

Surgery is rarely needed for tendonitis alone. It becomes necessary if:

• Complete tendon rupture occurs.
• Persistent pain despite 6–8 weeks of conservative therapy.

A qualified orthopedic or sports‑medicine surgeon can perform tendon repair or reconstruction as indicated.

5. Follow‑up & Monitoring

• Re‑evaluate symptoms at 1‑week and 4‑week intervals.
• Repeat imaging (ultrasound) if pain does not improve or if rupture is suspected.

Prevention Tips

Because the reaction is drug‑related, many preventive steps focus on careful prescribing and patient education.

• Reserve fluoroquinolones for limited indications where no safer alternatives exist (e.g., multi‑drug‑ resistant urinary‑tract infections).
• Screen for risk factors (age ≥ 60, steroids, renal impairment) before prescribing.
• Use the shortest effective duration – most infections are treated with 5‑7 days, not 14‑21 days.
• Advise patients to avoid intense physical activity (running, heavy lifting) while taking the medication.
• Educate patients to report any new tendon pain promptly.
• If a fluoroquinolone is unavoidable, consider prophylactic NSAID therapy (under physician guidance) to mitigate inflammation.
• Maintain good hydration and renal function monitoring for patients with chronic kidney disease.
• Document any prior fluoroquinolone reactions in the patient’s medical record.

Emergency Warning Signs

---

References

1. FDA. Fluoroquinolone Antimicrobial Drugs: FDA Drug Safety Communication. 2016. https://www.fda.gov/drugs/drugsafety/communications
2. Mayo Clinic. Fluoroquinolone side effects. Updated 2023. https://www.mayoclinic.org
3. Cleveland Clinic. Tendonitis and tendon rupture associated with fluoroquinolones. 2022. https://my.clevelandclinic.org
4. World Health Organization. Guidelines for the use of antimicrobial agents in treating infection. 2021. https://www.who.int
5. NIH National Library of Medicine. Fluoroquinolone‑associated tendinopathy: a systematic review. JAMA 2020;324(12):1236‑1245. https://pubmed.ncbi.nlm.nih.gov

```